ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
8.92
+0.66 (7.99%)
May 15, 2026, 4:00 PM EDT - Market closed
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $80.7 million as of May 18, 2026. Its market cap has increased by 68.33% in one year.
Market Cap
80.70M
Enterprise Value
86.66M
1-Year Change
68.33%
Ranking
Category
Stock Price
$8.92
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $80.70M, an increase of 3,951.08%. That is a compound annual growth rate of 11.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 80.70M | 45.06% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 85.11M |
| eXoZymes | 82.75M |
| OKYO Pharma | 82.39M |
| Rein Therapeutics | 81.94M |
| Atara Biotherapeutics | 81.55M |
| Adicet Bio | 80.65M |
| Fortress Biotech | 80.06M |
| Gossamer Bio | 79.80M |